| Literature DB >> 23667109 |
Torben Knuschke1, Viktoriya Sokolova, Olga Rotan, Munisch Wadwa, Matthias Tenbusch, Wiebke Hansen, Peter Staeheli, Matthias Epple, Jan Buer, Astrid M Westendorf.
Abstract
The ability of vaccines to induce T cell responses is crucial for preventing diseases caused by viruses or bacteria. Nanoparticles (NPs) are considered an efficient tool for inducing potent immune responses. In this study, we describe a novel vaccination approach with biodegradable calcium phosphate (CaP) NPs that serve as carrier of immunoactive TLR9 ligand (CpG) combined with a viral Ag from the influenza A virus hemagglutinin. Functionalized CaP NPs were efficiently taken up by dendritic cells in vivo and elicited a potent T cell-mediated immune response in immunized mice with high numbers of IFN-γ-producing CD4(+) and CD8(+) effector T cells. Most importantly, both i.p. and intranasal immunization with these NPs offered protection in a mouse model of influenza virus infection. This study demonstrates the great potential of CaP NPs as a novel vaccination tool that offers substantial flexibility for several infection models.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23667109 DOI: 10.4049/jimmunol.1202654
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422